REGENXBIO logo

REGENXBIO Employee Directory

Biotechnology ResearchMaryland, United States201-500 Employees

REGENXBIO is a clinical-stage biotechnology company based in Rockville, Maryland, at 9804 Medical Center Drive, Rockville, MD 20850, United States. Founded in 2009, the company has developed the AAV Therapeutics platform, a gene therapy modality intended to be one-time treatments. It is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for wet AMD and diabetic retinopathy through a collaboration with AbbVie, RGX-202 for Duchenne muscular dystrophy, and RGX-121 for MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for spinal muscular atrophy. The company operates in the biotechnology research industry and employs between 201 and 500 people.

Find REGENXBIO employees' phone numbers or email addresses

REGENXBIO Global Highlights

Location
Employees

North America
495

Minus sign iconPlus sign icon
  • United States Of America
    494
  • Canada
    1

Asia
5

Minus sign iconPlus sign icon
  • Saudi Arabia
    1
  • India
    1
  • Bangladesh
    1
  • Singapore
    1
  • Indonesia
    1

Europe
4

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Netherlands
    1
  • Belgium
    1

Africa
2

Minus sign iconPlus sign icon
  • Nigeria
    1
  • South Africa
    1

REGENXBIO's Leadership

  • Vice President Sales at REGENXBIO
    K. S.
    Vice President Sales
  • President at REGENXBIO
    X. Z.
    President
  • Head Of Formulation And Drug Product Development at REGENXBIO
    J. B.
    Head Of Formulation And Drug Product Development
  • Head Of Medical Affairs, Rare at REGENXBIO
    K. T.
    Head Of Medical Affairs, Rare
  • Head Of Investor Relations at REGENXBIO
    T. T.
    Head Of Investor Relations
  • Senior Vice President, Finance at REGENXBIO
    M. M.
    Senior Vice President, Finance
  • Executive Director / Head Manufacturing Sciences at REGENXBIO
    J. H.
    Executive Director / Head Manufacturing Sciences
  • Senior Director Medical Affairs (retina Gene Therapy) at REGENXBIO
    R. S.
    Senior Director Medical Affairs (retina Gene Therapy)

REGENXBIO Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Manufacturing
  • Operations
  • Program & Project Management
  • Other
  • Biotechnology
  • Administrative
  • Legal
  • Quality Assurance
  • Business

Contact profiles from REGENXBIO

Name
Title
Contact
Location
Last Update
  • Director at REGENXBIO
    K. M.
    Director
    Aug 15, 2026
  • Director, Organization Development & Internal Communications at REGENXBIO
    S. O.
    Director, Organization Development & Internal Communications
    Jun 24, 2026
  • Senior Director, Financial Planning And Analysis at REGENXBIO
    B. C.
    Senior Director, Financial Planning And Analysis
    Sep 02, 2026
  • Director Of Ophthalmology Research at REGENXBIO
    B. L.
    Director Of Ophthalmology Research
    Sep 02, 2026
  • Executive Director at REGENXBIO
    Y. C.
    Executive Director
    Apr 16, 2026
  • Associate Director, Quality Opeartions at REGENXBIO
    K. W.
    Associate Director, Quality Opeartions
    Apr 15, 2026
  • Senior Director, Downstream Pd And Process Validation at REGENXBIO
    M. W.
    Senior Director, Downstream Pd And Process Validation
    Sep 01, 2026
  • Associate Director at REGENXBIO
    A. B.
    Associate Director
    Jun 12, 2026
  • Senior Director, Corporate Counsel at REGENXBIO
    E. K.
    Senior Director, Corporate Counsel
    Jun 10, 2026
  • Associate Director, Cell Line Development at REGENXBIO
    M. S. E.
    Associate Director, Cell Line Development
    Jul 07, 2026

Frequently Asked Questions

What is REGENXBIO known for?

Minus sign iconPlus sign icon
REGENXBIO was founded in 2008 and operates in the Biotechnology Research industry. You can contact REGENXBIO's main corporate office by phone at . Explore REGENXBIO's company overview page for more information.

What is REGENXBIO's most common email format?

Minus sign iconPlus sign icon
REGENXBIO employees' email format typically follows the pattern of FLast@regenxbio.com. Trying to find reliable and up-to-date employee contact data? Find more REGENXBIO email formats with LeadIQ.

How many employees does REGENXBIO have currently?

Minus sign iconPlus sign icon
REGENXBIO has approximately 389 employees as of August 2026. These team members are located across 4 continents, including North America, Asia and Europe.

Who are REGENXBIO's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, REGENXBIO's key employees include:

  • Vice President Sales: K. S.
  • President: X. Z.
  • Head Of Formulation And Drug Product Development: J. B.
  • Head Of Medical Affairs, Rare: K. T.
  • Head Of Investor Relations: T. T.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.